The Treatment of Resistant Nephrotic Syndrome with Acthar Gel (ACTH)

Share this content:


Andrew S. Bomback, MD, MPH, Assistant Professor of Clinical Medicine, Columbia University, New York discusses his study on the treatment of resistant nephrotic syndrome with Acthar Gel (ACTH) during Renal Week 2010 in Denver.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters